Back to search

Preoperative/neoadjuvant medical therapy for early breast cancer

Data up to Jan 2025

Published2001
Citations75
References38
Clinical Trials (1)

Total Citations Per Year

Abstract

References (38)

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

1998 • 2,115 citations

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

1999 • 1,315 citations

Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group

2001 • 1,019 citations

Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

2000 • 990 citations

Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

2000 • 841 citations

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.

1998 • 581 citations

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

1988 • 511 citations

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6

1994 • 435 citations

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up

1999 • 433 citations

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

1995 • 348 citations

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

1998 • 322 citations

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm

1991 • 277 citations

Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer

1978 • 275 citations

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer

1990 • 267 citations

Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast Cancer

1999 • 253 citations

Multimodal treatment of locoregionally advanced breast cancer

1983 • 246 citations

Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer

1994 • 208 citations

Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone

1991 • 193 citations

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.

1995 • 186 citations

Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.

1982 • 184 citations

PROSPECTIVE RANDOMISED TRIAL OF TAMOXIFEN VERSUS SURGERY IN ELDERLY PATIENTS WITH BREAST CANCER

1988 • 159 citations

Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.

1997 • 156 citations

The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study.

2000 • 148 citations

Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.

1988 • 145 citations

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer

2000 • 128 citations

Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial

1999 • 124 citations

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.

1998 • 117 citations

Primary medical (neo-adjuvant) chemotherapy for operable breast cancer

1993 • 104 citations

A Personal Experience with Halstedʼs Radical Mastectomy

1984 • 81 citations

Primary systemic therapy for operable breast cancer

1991 • 78 citations

Primary systemic therapy for operable breast cancer - 10-year survival data after chemotherapy and hormone therapy

1997 • 74 citations

A HUMAN TUMOUR MODEL

1986 • 74 citations

Proliferating Fraction During Neoadjuvant Chemotherapy of Primary Breast Cancer in Relation to Objective Local Response and Relapse-free Survival

1999 • 60 citations

Primary medical therapy for operable breast cancer

1989 • 48 citations

Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy

2000 • 41 citations

Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy

2000 • 34 citations

Neo-adjuvant chemotherapy for operable breast cancer induces apoptosis

1999 • 26 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

Preoperative/neoadjuvant medical therapy for early breast cancer (2001) – The Lancet Oncology | Metascience Observatory Explorer